跳至主要内容
临床试验/IRCT20170722035232N1
IRCT20170722035232N1招募中未知

The Effects of Cool Dialysate on Restless Leg Syndrome (RLS) in Patients Treated with Hemodialysis

Sabzevar University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Informed consent to participate in the study
  • Full consciousness and acceptable verbal and auditory ability to answer the questions
  • The patient should not suffer from obvious mental disorder and severe mood - emotional disturbance that prevents effective communication
  • The patient should be in normal neurological and vascular status.
  • Lack of muscular and skeletal disorders debilitating physical activity
  • Lack of ulcer and redness in limbs
  • Patients with chronic renal failure (Patients who have been undergoing hemodialysis for 3 months).
  • Patients who have an arteriovenous fistula, permanent catheter and arterial-venous graft can access their vessels.
  • Patients undergoing hemodialysis three times a week and 4 hours each session.
  • Patients who have had a history of restless leg syndrome during the past 2 months of hemodialysis.
  • Lack of endocrine disorders (such as hypothyroidism and hyperparathyroidism).
  • No history of itchy skin diseases
  • Do not use medicines or foods that they exacerbate the leg syndrome during dialysis, such as: neuroleptics, triangular antidepressants, diphenhydramine, caffeine, alcohol, lithium, beta-blockers, selective serotonin reuptake inhibitors, and serotonin-norepinephrine reuptake inhibitors.
  • Lack of liver problems
  • No medication or treatments that affect on restless leg syndrome during dialysis(oral medicines, complementary medicine, acupuncture and topical softeners).
  • Patients with KT / V =1
  • Patients with hemoglobin 10-11 mg / dL.
  • Lack of febrile illness and chronic infections (pneumonia, cold during hemodialysis).
  • Use of bicarbonate dialysis solution

排除标准

  • Patients with catabolic processes such as: malignancies
  • Diabetic neuropathy
  • Cases of chronic infections, heart failure, chronic pulmonary disease, severe anemia, coronary artery disease and drug abuse

研究者

发起方
Sabzevar University of Medical Sciences

相似试验